The vaccine delivery devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Vaccine Delivery Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The vaccine delivery devices market size has grown rapidly in recent years. It will grow from $5.81 billion in 2023 to $6.39 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to large-scale polio vaccination campaigns, expanded program on immunization (EPI), the adoption of disposable syringes, smallpox eradication efforts, initiatives including the global alliance for vaccines and immunization (GAVI) and the vaccine alliance.
The vaccine delivery devices market size is expected to see rapid growth in the next few years. It will grow to $9.45 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pediatric and geriatric populations, focus on cold chain management, and raising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include the continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, new self-administered vaccines, and the partnerships.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/vaccine-delivery-devices-global-market-report
Scope Of Vaccine Delivery Devices Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Vaccine Delivery Devices Market Overview
Market Drivers –
The vaccine delivery devices market size has grown rapidly in recent years. It will grow from $5.81 billion in 2023 to $6.39 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to large-scale polio vaccination campaigns, expanded program on immunization (EPI), the adoption of disposable syringes, smallpox eradication efforts, initiatives including the global alliance for vaccines and immunization (GAVI) and the vaccine alliance.
The vaccine delivery devices market size is expected to see rapid growth in the next few years. It will grow to $9.45 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pediatric and geriatric populations, focus on cold chain management, and raising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include the continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, new self-administered vaccines, and the partnerships.
Market Trends –
Major companies operating in the vaccine delivery devices market are developing innovative products, such as prefillable syringes, to enhance the efficiency and safety of vaccine administration. Prefillable syringes are drug delivery devices specifically designed to contain and administer a predetermined dose of medication, typically in liquid form for vaccines. For instance, in September 2022, Becton, Dickinson, and Company (BD), a US-based medical technology company, launched the BD Effivax Glass Prefillable Syringe, a next-generation vaccine delivery device designed to meet the evolving needs of vaccine manufacturing. The syringe aims to improve reliability and efficiency in vaccine administration with enhanced technology and tightened specifications. It offers increased fill or finish and container reliability to help reduce the risk of line stoppage and enhance manufacturing capacity.
The vaccine delivery devices market covered in this report is segmented –
1) By Type Of Device: Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Other Vaccinations
3) By End Users: Hospitals, Clinics, Other End Users
Get an inside scoop of the vaccine delivery devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15952&type=smp
Regional Insights –
North America was the largest region in the vaccine delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the vaccine delivery devices market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis International AG, AstraZeneca PLC, 3M Company, GlaxoSmithKline plc, Moderna Inc., Becton Dickinson and Company (BD), Sinovac Biotech Co. Ltd., CSL Limited, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Dynavax Technologies Corporation, CanSino Biologics Inc., Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, Panacea Biotec Limited
Table of Contents
1. Executive Summary
2. Vaccine Delivery Devices Market Report Structure
3. Vaccine Delivery Devices Market Trends And Strategies
4. Vaccine Delivery Devices Market – Macro Economic Scenario
5. Vaccine Delivery Devices Market Size And Growth
…..
27. Vaccine Delivery Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outloo
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
